Impaired Metabolic Flexibility to High-Fat Overfeeding Predicts Future Weight Gain in Healthy Adults.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
02 2020
Historique:
received: 21 07 2019
accepted: 07 11 2019
pubmed: 13 11 2019
medline: 3 7 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

The ability to switch fuels for oxidation in response to changes in macronutrient composition of diet (metabolic flexibility) may be informative of individuals' susceptibility to weight gain. Seventy-nine healthy, weight-stable participants underwent 24-h assessments of energy expenditure and respiratory quotient (RQ) in a whole-room calorimeter during energy balance (EBL) (50% carbohydrate, 30% fat) and then during 24-h fasting and three 200% overfeeding diets in a crossover design. Metabolic flexibility was defined as the change in 24-h RQ from EBL during fasting and standard overfeeding (STOF) (50% carbohydrate, 30% fat), high-fat overfeeding (HFOF) (60% fat, 20% carbohydrate), and high-carbohydrate overfeeding (HCOF) (75% carbohydrate, 5% fat) diets. Free-living weight change was assessed after 6 and 12 months. Compared with EBL, RQ decreased on average by 9% during fasting and by 4% during HFOF but increased by 4% during STOF and by 8% during HCOF. A smaller decrease in RQ, reflecting a smaller increase in lipid oxidation rate, during HFOF but not during the other diets predicted greater weight gain at both 6 and 12 months. An impaired metabolic flexibility to acute HFOF can identify individuals prone to weight gain, indicating that an individual's capacity to oxidize dietary fat is a metabolic determinant of weight change.

Identifiants

pubmed: 31712321
pii: db19-0719
doi: 10.2337/db19-0719
pmc: PMC6971489
doi:

Substances chimiques

Dietary Carbohydrates 0
Dietary Fats 0

Banques de données

ClinicalTrials.gov
['NCT00523627']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-192

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 by the American Diabetes Association.

Références

J Clin Endocrinol Metab. 2017 Jan 1;102(1):279-289
pubmed: 27820654
Am J Physiol. 1990 Nov;259(5 Pt 1):E650-7
pubmed: 2240203
Diabetes. 2008 Apr;57(4):841-5
pubmed: 18285553
N Engl J Med. 1990 May 24;322(21):1477-82
pubmed: 2336074
Am J Physiol. 1999 Dec;277(6):E1130-41
pubmed: 10600804
Int J Obes Relat Metab Disord. 1999 Jul;23(7):715-22
pubmed: 10454105
Proc Nutr Soc. 2004 May;63(2):369-74
pubmed: 15294057
Diabetes. 2015 Nov;64(11):3680-9
pubmed: 26185280
Am J Clin Nutr. 1992 Oct;56(4):641-55
pubmed: 1414963
J Clin Invest. 1985 Apr;75(4):1106-15
pubmed: 3886702
Eur J Clin Nutr. 2000 Aug;54(8):610-4
pubmed: 10951508
Diabetes. 2000 May;49(5):677-83
pubmed: 10905472
Obes Res. 1995 Sep;3 Suppl 2:155s-163s
pubmed: 8581771
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S109-19
pubmed: 19136979
J Clin Invest. 1986 Dec;78(6):1568-78
pubmed: 3782471
J Clin Endocrinol Metab. 1998 Aug;83(8):2758-64
pubmed: 9709943
Am J Clin Nutr. 2007 Sep;86(3):625-32
pubmed: 17823426
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Obesity (Silver Spring). 2018 Nov;26(11):1758-1766
pubmed: 30358145
Obesity (Silver Spring). 2010 Dec;18(12):2255-9
pubmed: 20448540
Obesity (Silver Spring). 2017 Jan;25(1):207-214
pubmed: 27868388
Cell Metab. 2018 Jul 03;28(1):45-54.e3
pubmed: 29861390
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):471-82
pubmed: 16311212
Annu Rev Nutr. 1987;7:187-208
pubmed: 3300732
Metabolism. 2004 May;53(5):655-9
pubmed: 15131773
Obesity (Silver Spring). 2019 May;27(5):691-699
pubmed: 31012296
J Clin Endocrinol Metab. 2013 Apr;98(4):E703-7
pubmed: 23418317
Int J Obes Relat Metab Disord. 1992 Sep;16(9):667-74
pubmed: 1328091
Int J Obes Relat Metab Disord. 1998 Jun;22(6):601-3
pubmed: 9665683
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1009-17
pubmed: 18765680
Int J Obes (Lond). 2010 May;34(5):886-91
pubmed: 20195283
Am J Physiol. 1988 Sep;255(3 Pt 1):E332-7
pubmed: 3421330
Obes Rev. 2011 Oct;12(10):859-65
pubmed: 21692967
Eur J Clin Nutr. 2017 Mar;71(3):318-322
pubmed: 27848941
Diabetes Metab Rev. 1988 Sep;4(6):571-81
pubmed: 3065010
Ann N Y Acad Sci. 1993 Jun 14;683:122-40
pubmed: 8352435
Ann N Y Acad Sci. 1997 Sep 20;827:417-30
pubmed: 9329772
Diabetes. 2015 Aug;64(8):2859-67
pubmed: 25964395
Int J Obes (Lond). 2013 Sep;37(9):1192-7
pubmed: 23229737
N Engl J Med. 1995 Mar 9;332(10):621-8
pubmed: 7632212
J Clin Endocrinol Metab. 2013 Jul;98(7):2791-9
pubmed: 23666976
J Clin Invest. 1995 Mar;95(3):980-5
pubmed: 7883999
J Clin Invest. 1987 Aug;80(2):566-72
pubmed: 3301902

Auteurs

Brittany Begaye (B)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.

Karyne L Vinales (KL)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.
Endocrinology Division, Medicine Department, Phoenix VA Health Care System, Phoenix, AZ.

Tim Hollstein (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.

Takafumi Ando (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.

Mary Walter (M)

Clinical Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Clifton Bogardus (C)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.

Jonathan Krakoff (J)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ.

Paolo Piaggi (P)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, AZ paolo.piaggi@gmail.com paolo.piaggi@nih.gov.
Department of Information Engineering, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH